Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Stickel

Showing results (101-110 of 169) with videos related to

Pageof 17
Sort By:
Alcoholism, Clinical and Experimental Research|November 10, 2017
Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and FibrosisSebastian Mueller, Teresa Peccerella, Hua Qin, et al.
Hepatobiliary Surgery and Nutrition|January 7, 2016
Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH)Ulrike Teufel, Teresa Peccerella, Guido Engelmann, et al.
Clinical Chemistry and Laboratory Medicine|March 13, 2009
Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Jan Petrásek, Jaroslav A Hubácek, Felix Stickel, et al.
Anti-Cancer Drugs|October 11, 2003
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatinFelix Stickel, Barbara Jüngert, Valeska Brueckl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver diseaseSebastian K Eder, Alexandra Feldman, Georg Strebinger, et al.
Antiviral Therapy|September 17, 2013
Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individualsJanine Rohrbach, Felix Stickel, Patrick Schmid, et al.
Hormones & Cancer|May 30, 2015
Parathyroid Hormone is Related to Dysplasia and a Higher Rate of Distal Colorectal Adenoma in Women but Not MenElmar Aigner, Andreas Stadlmayr, Ursula Huber-Schönauer, et al.
Journal of Clinical Medicine|November 30, 2018
Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific AnalysisDavid Niederseer, Isabelle Bracher, Andreas Stadlmayr, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
International Journal of Cancer|November 16, 2005
Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkersNils Homann, Felix Stickel, Inke R König, et al.
Pageof 17

Showing results (101-110 of 169) with videos related to

Sort By:
Pageof 17
Alcoholism, Clinical and Experimental Research|November 10, 2017
Carcinogenic Etheno DNA Adducts in Alcoholic Liver Disease: Correlation with Cytochrome P-4502E1 and FibrosisSebastian Mueller, Teresa Peccerella, Hua Qin, et al.
Hepatobiliary Surgery and Nutrition|January 7, 2016
Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH)Ulrike Teufel, Teresa Peccerella, Guido Engelmann, et al.
Clinical Chemistry and Laboratory Medicine|March 13, 2009
Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?Jan Petrásek, Jaroslav A Hubácek, Felix Stickel, et al.
Anti-Cancer Drugs|October 11, 2003
Weekly high-dose 5-fluorouracil as 24-h infusion and folinic acid (AIO) plus irinotecan as second- and third-line treatment in patients with colorectal cancer pre-treated with AIO plus oxaliplatinFelix Stickel, Barbara Jüngert, Valeska Brueckl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 8, 2020
Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver diseaseSebastian K Eder, Alexandra Feldman, Georg Strebinger, et al.
Antiviral Therapy|September 17, 2013
Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individualsJanine Rohrbach, Felix Stickel, Patrick Schmid, et al.
Hormones & Cancer|May 30, 2015
Parathyroid Hormone is Related to Dysplasia and a Higher Rate of Distal Colorectal Adenoma in Women but Not MenElmar Aigner, Andreas Stadlmayr, Ursula Huber-Schönauer, et al.
Journal of Clinical Medicine|November 30, 2018
Association between Cardiovascular Risk and Diabetes with Colorectal Neoplasia: A Site-Specific AnalysisDavid Niederseer, Isabelle Bracher, Andreas Stadlmayr, et al.
The Journal of Clinical Endocrinology and Metabolism|May 13, 2021
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of MortalityGeorg Semmler, Sarah Wernly, Sebastian Bachmayer, et al.
International Journal of Cancer|November 16, 2005
Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkersNils Homann, Felix Stickel, Inke R König, et al.
Pageof 17